23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

from NYT > Business https://ift.tt/MtkVR6o